On 8/23/24, CorMedix Inc (NASDAQ: CRMD) stock enjoyed a major increase of 10.8%, closing at $5.65. Moreover, unusually high trading volume at 190% of normal accompanied the advance. The stock has been exceptionally strong relative to the market over the last nine months and has risen 17.8% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, CRMD is expected to continue to be Value Creation neutral.
CorMedix has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. CorMedix has a very low Appreciation Score of 3 but a very high Power Rating of 94, with the Neutral Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment